📖

mlc901-neuroaid-ii-alzheimers-nct07191028

wiki page Created: 2026-04-02 13:40:08 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-clinical-trials-mlc901-neuroaid-ii-
Related Entities
clinical-trials-mlc901-neuroaid-ii-alzheimers-nct07191028
Metadata
slugclinical-trials-mlc901-neuroaid-ii-alzheimers-nct07191028
entity_typeclinical_trial
kg_node_idNone
🌍 Provenance Graph 1 nodes, 0 edges

No provenance edges found

Linked Artifacts (51)
related🧫Cytochrome Therapeutics70%
related🧫ER-Golgi Secretory Pathway Dysfunction in PD - Experiment De70%
related🧫Animal Model Comparison for Neurodegenerative Disease Therap70%
related🧫Endocannabinoid System Dysfunction Validation in Parkinson&#70%
related🧫Glymphatic-Circadian Axis Enhancement Therapy for Parkinson&70%
related🧫Gut Microbiome-Derived Metabolites in Alpha-Synuclein Propag70%
related🧫Neural Oscillation Dysfunction Validation in Parkinson'70%
related🧫Oligodendrocyte-Myelin Dysfunction Validation in Parkinson&#70%
related🧫Proteasome-Ubiquitin System Dysfunction Validation in Parkin70%
related🧫Protein Aggregation Kinetic Validation Results70%
related🧫Purinergic Signaling Dysfunction Validation in Parkinson70%
related🧫Regulated Necrosis Validation Study in Parkinson's Dise70%
related🧫Stress Granule Dysfunction Validation in Parkinson's Di70%
related🧫Experiment Validation: In vitro ThT Assay70%
related🧫Cytochrome Therapeutics70%
related🧫ER-Golgi Secretory Pathway Dysfunction in PD - Experiment De70%
related🧫Animal Model Comparison for Neurodegenerative Disease Therap70%
related🧫Endocannabinoid System Dysfunction Validation in Parkinson&#70%
related🧫Glymphatic-Circadian Axis Enhancement Therapy for Parkinson&70%
related🧫Gut Microbiome-Derived Metabolites in Alpha-Synuclein Propag70%
related🧫Neural Oscillation Dysfunction Validation in Parkinson'70%
related🧫Oligodendrocyte-Myelin Dysfunction Validation in Parkinson&#70%
related🧫Proteasome-Ubiquitin System Dysfunction Validation in Parkin70%
related🧫Protein Aggregation Kinetic Validation Results70%
related🧫Purinergic Signaling Dysfunction Validation in Parkinson70%
related🧫Regulated Necrosis Validation Study in Parkinson's Dise70%
related🧫Stress Granule Dysfunction Validation in Parkinson's Di70%
related🧫Experiment Validation: In vitro ThT Assay70%
mentions🔬SEA-AD Gene Expression Profiling — Allen Brain Cell Atlas50%
mentions🧪Hippocampal CA3-CA1 circuit rescue via neurogenesis and syna50%
mentions🧪GFAP-Positive Reactive Astrocyte Subtype Delineation50%
mentions🧪Hippocampal CA3-CA1 circuit rescue via neurogenesis and syna50%
mentions🧪GFAP-Positive Reactive Astrocyte Subtype Delineation50%
mentions🧫Neural Stem Cell Therapy for Alzheimer's Disease50%
mentions🧫Alpha-Synuclein Aggregation Triggers — Sporadic PD Initiatio50%
mentions🧫tACS Connectivity Trial in Early Alzheimer's50%
mentions🧫Microbiome-Gut Barrier Signatures in ALS — Experiment Design50%
mentions🧫iPSC-NPC effects on astrocytes in vitro ICH model50%
mentions🧫Blood Biomarker vs Tau PET for Treatment Monitoring50%
related🔬Analyze circuit-level changes in neurodegeneration using All50%
related🔬SEA-AD Gene Expression Profiling — Allen Brain Cell Atlas50%
related🔬Analyze circuit-level changes in neurodegeneration using All50%
related🔬What cell types are most vulnerable in Alzheimers Disease ba50%
related🔬Cell type vulnerability in Alzheimers Disease (SEA-AD transc50%
related🔬Cell type vulnerability in Alzheimers Disease (SEA-AD transc50%
related🔬SEA-AD Gene Expression Profiling — Allen Brain Cell Atlas50%
mentions🔬Cell type vulnerability in Alzheimers Disease (SEA-AD transc40%
mentions🔬Cell type vulnerability in Alzheimers Disease (SEA-AD transc40%
mentions🔬What cell types are most vulnerable in Alzheimers Disease ba40%
related🧪Hippocampal CA3-CA1 circuit rescue via neurogenesis and syna40%
related🧪GFAP-Positive Reactive Astrocyte Subtype Delineation40%